<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE OF REVIEW: Genetic testing for the presence of germline mutations in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-predisposing genes can identify individuals at increased <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk </plain></SENT>
<SENT sid="1" pm="."><plain>For these individuals, the institution of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> surveillance measures is recommended with the aim of detecting <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> at early and hence more curable stages </plain></SENT>
<SENT sid="2" pm="."><plain>While these principles are well established in adults, they are only entering the pediatric arena </plain></SENT>
<SENT sid="3" pm="."><plain>RECENT FINDINGS: The care of children with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-predisposing conditions remains a challenge for the practicing clinician </plain></SENT>
<SENT sid="4" pm="."><plain>Here, we describe recent findings related to genetic testing and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> surveillance in three conditions marked by the development of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> during childhood, including <z:hpo ids='HP_0009919'>retinoblastoma</z:hpo>, <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e>/idiopathic <z:hpo ids='HP_0001528'>hemihypertrophy</z:hpo> and the <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumor</z:e>-associated syndromes </plain></SENT>
<SENT sid="5" pm="."><plain>We use these conditions to demonstrate how the integration of clinical genetic testing and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> monitoring has favorably influenced the survival and quality of life for patients </plain></SENT>
<SENT sid="6" pm="."><plain>Where possible, we provide evidence-based guidelines for patient management </plain></SENT>
<SENT sid="7" pm="."><plain>SUMMARY: Advances in the understanding of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> predisposition and implementation of standardized <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> surveillance protocols have improved the outcome for certain patients </plain></SENT>
<SENT sid="8" pm="."><plain>Future research focusing on enhancing the sensitivity of genetic testing and efficacy of surveillance for at-risk populations could further decrease the morbidity and mortality associated with these conditions </plain></SENT>
</text></document>